Guru Ownership Trend
Guru Analysis for Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. (RARE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $138.72 M.
Top institutional holders include Frank Sands and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $24.52 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who dramatically increased their stake. Conversely, Paul Tudor Jones reduced exposure by 77.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Ultragenyx Pharmaceutical Inc. (RARE)
Major holders include Frank Sands ($80.17 M), Cliff Asness ($31.29 M), Jefferies Group ($10.97 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 6.1 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $24.52 M, with 4 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited RARE. The total reported sell value was $9.2 M.
Yes, 1 managers opened new positions in RARE, and 3 increased their existing holdings. The total reported buy value was $33.72 M.
